L. Levesque et al., ANTISENSE OLIGONUCLEOTIDES TARGETING HUMAN PROTEIN-KINASE C-ALPHA INHIBIT PHORBOL ESTER-INDUCED REDUCTION OF BRADYKININ-EVOKED CALCIUM MOBILIZATION IN A549 CELLS, Molecular pharmacology, 51(2), 1997, pp. 209-216
Regulation of the bradykinin-evoked increase in intracellular Ca2+ con
centration by protein kinase C (PKC)-alpha was investigated in A549 hu
man lung carcinoma cells. Bradykinin, a potent and selective kinin B-2
receptor agonist, induces calcium mobilization in a concentration-dep
endent fashion in this cell line. 12-O-Tetradecanoylphorbol-13-acetate
(TPA), a potent activator of PKC, is known to reduce the amplitude of
agonist-induced calcium mobilization in various cell lines. Because P
KC-alpha is a major PKC isozyme in A549 cells, we investigated whether
this isozyme plays a role in this process. A 20-mer phosphorothioate
oligonucleotide targeting the 3'-untranslated region of the human PKC-
alpha mRNA, which contains 2'-methoxyethyl modifications incorporated
into the 5' and 3' segments of the oligonucleotide, was used to assess
the putative role of PKC-alpha in the receptor regulation. ISIS 9606
reduced PKC-alpha mRNA for greater than or equal to 72 hr after the in
itial treatment and the reduction was concentration dependent, whereas
the mismatch control, ISIS 13009, had no effect. Concentrations of IS
IS 9606 of 150 nM specifically reduced the level of immunoreactive PKC
-alpha protein by 66.3 +/- 2.5% at 72 hr after treatment, without an e
ffect on immunoreactive PKC-delta protein. This reduction in PKC-alpha
was sufficient to inhibit the reduction of bradykinin-induced calcium
mobilization by TPA. This finding is corroborated by the use of staur
osporine, a nonselective PKC inhibitor, that prevented the effect of T
PA. These results suggest that PKC-alpha is involved in kinin B-2 rece
ptor regulation by phorbol esters in A549 cells.